Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?

Abstract

Current guidelines recommend reducing the daily intake of dietary fats for the prevention of ischemic cardiovascular diseases (CVDs). Avoiding saturated fats while increasing the intake of mono- or polyunsaturated fatty acids has been for long time the cornerstone of dietary approaches in cardiovascular prevention, mainly due to the metabolic effects of these molecules. However, recently, this approach has been critically revised. The experimental evidence, in fact, supports the concept that the pro- or anti-inflammatory potential of different dietary fats contributes to atherogenic or anti-atherogenic cellular and molecular processes beyond (or in addition to) their metabolic effects. All these aspects are hardly translatable into clinics when trying to find connections between the pro-/anti-inflammatory potential of dietary lipids and their effects on CVD outcomes. Interventional trials, although providing stronger potential for causal inference, are typically small sample-sized, and they have short follow-up, noncompliance, and high attrition rates. Besides, observational studies are confounded by a number of variables and the quantification of dietary intakes is far from optimal. A better understanding of the anatomic and physiological barriers for the absorption and the players involved in the metabolism of dietary lipids (e.g., gut microbiota) might be an alternative strategy in the attempt to provide a first step towards a personalized dietary approach in CVD prevention.

The Impact of Diet and Physical Activity on Psoriasis: A Narrative Review of the Current Evidence

“…Lipids play a special role in modulating inflammation. Saturated fats (SFAs) found, among others, in butter and red meat increase the concentration of interleukins and contribute to the development of inflammation [ 17 ]. Similarly, the pro-inflammatory effect may also be exerted by an excess of unsaturated fatty acids from the n -6 family, present, for example, in margarine and refined vegetable oils [ 18 ].…”

Liver-derived lipoproteins and inflammation: from pathophysiology to pharmacological targets in metabolic liver disease

“…It may be theorised that the increased particle size of the lipids in sustained or alimentary hyperlipemia is the stimulus to the phagocytosis in the intima by macrophages and the formation of the typical foam cells" [35,36] . This pioneering concept anticipated the subsequent data indicating that ApoB containing VLDL is surveilled by immune-inflammatory checkpoints, and, by entering the sub-endothelial layer of vasculature, they directly contribute to the inflammatory mechanisms, including cholesterol deposition and prothrombotic effects [37][38][39][40][41][42] , involved in the progression of atherosclerosis. Within these mechanisms, however, the experimental evidence produced thus far still questions whether it is the ApoB lipoprotein per se, or it is more likely their content of the aryl carbon chains of TG (fatty acids) or that of cholesterol [43] .…”

The High Fat Diet Impacts the Plasticity between Fresh and Aged Neutrophils

“…Also, cardio-metabolic risk factors trigger an excessive response of the inflammasome, and among them, cholesterol has been identified as a key inducer of the long-term hyper-activation of hematopoietic stem cells (HSCs) residing in the BM. This occurs by establishing a functional epigenetic response known as “trained immunity” [ 9 – 11 ], which affects the activity of a wide set of transcription factors and protein-DNA epigenetic regulators of HSCs physiology [ 14 ]. In addition to cholesterol, hyperglycemia also elicits trained immunity of BM-derived macrophages and their precursors, although this occurs via epigenetic activation of the Runt-related transcription factor 1 (Runx1) [ 12 ], a crucial transcription factor that regulates the leukemogenic expansion of HSCs.…”